Stock Events

Stock Events

60 Degrees Pharmaceuticals 

$0.9193
27
-$0.01-1.16% Friday 19:59
+$0.03+3.39%Friday 20:00After hours

Statistics

Day High
0.9504
Day Low
0.9193
52W High
8.62
52W Low
0.8969
Volume
920
Avg. Volume
-
Mkt Cap
3.23M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

12NovExpected
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q1 2026
Q2 2026
Next
-4.01
-2.88
-1.74
-0.61
Expected EPS
-0.61
Actual EPS
N/A

Financials

-523.08%Profit Margin
Unprofitable
2022
2023
2024
2025
1.41MRevenue
-7.37MNet Income

Analyst Ratings

3.70Average Price Target
The highest estimate is 3.70.
From 1 ratings within the last 6 months. This is not an investment recommendation.
Buy
100%
Hold
0%
Sell
0%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow SXTP. It's not an investment recommendation.
Tesla
5
TSLA
Microsoft
4
MSFT
Meta Platforms
4
META
Legal & General Group
4
LGEN.LSE

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Gilead Sciences
GILD
Mkt Cap187.23B
Gilead Sciences is a biopharmaceutical company that competes with 60 Degrees Pharmaceuticals in the development and marketing of treatments for infectious diseases, including those in tropical regions.
Pfizer
PFE
Mkt Cap162.16B
Pfizer is a global pharmaceutical corporation that competes across various therapeutic areas, including infectious diseases, which overlaps with 60 Degrees Pharmaceuticals' focus.
Merck
MRK
Mkt Cap370.89B
Merck & Co. is involved in the discovery, development, manufacturing, and marketing of pharmaceuticals for infectious diseases, directly competing with 60 Degrees Pharmaceuticals.
Johnson & Johnson
JNJ
Mkt Cap663.28B
Johnson & Johnson, through its pharmaceutical segment Janssen, competes in the area of infectious diseases, offering treatments that could be alternatives to those developed by 60 Degrees Pharmaceuticals.
Abbvie
ABBV
Mkt Cap453.19B
AbbVie competes in the pharmaceuticals market, including infectious diseases, with a strong emphasis on research and development, making it a competitor to 60 Degrees Pharmaceuticals.
Novartis
NVS
Mkt Cap304.1B
Novartis is a global healthcare company that has a broad portfolio, including treatments for infectious diseases, competing with 60 Degrees Pharmaceuticals.
GSK
GSK
Mkt Cap99.96B
GlaxoSmithKline focuses on pharmaceuticals and vaccines for infectious diseases, directly competing with 60 Degrees Pharmaceuticals in this therapeutic area.
Sanofi
SNY
Mkt Cap106.01B
Sanofi is a global biopharmaceutical company focused on human health, including infectious diseases, making it a competitor to 60 Degrees Pharmaceuticals.
Bristol-Myers Squibb
BMY
Mkt Cap136.49B
Bristol Myers Squibb is a global biopharmaceutical company with a focus on discovering, developing, and delivering innovative medicines, including for infectious diseases, competing with 60 Degrees Pharmaceuticals.
Astrazeneca
AZN
Mkt Cap252.33B
AstraZeneca is a global, science-led biopharmaceutical business that operates in various therapeutic areas, including infectious diseases, making it a competitor to 60 Degrees Pharmaceuticals.

About

60 Degrees Pharmaceuticals Inc operates as a specialty pharmaceutical company with the goal of using biological science and applied research to develop and commercialize new therapies for the prevention and treatment of infectious diseases. Currently, company's pipeline under development covers development programs for vector-borne, fungal, and viral diseases utilizing three of the Company's future products: (i) new products that contain the Arakoda regimen of Tafenoquine; (ii) new products that contain Tafenoquine; and (iii) Celgosivir and/or botanical extracts from Australian Chestnut Trees.
Show more...
CEO
Geoffrey Stuart Dow
Employees
3
Country
United States
ISIN
US83006G5009

Listings

XNAS
US
SXTP
XNAS
US
SXTPW
BOATS
BOATS
SXTP.BOATS

0 Comments

Share your thoughts

FAQ

What is 60 Degrees Pharmaceuticals stock price today?▼
The current price of SXTP is $0.92 USD — it has decreased by -1.16% in the past 24 hours. Watch 60 Degrees Pharmaceuticals stock price performance more closely on the chart.
What is 60 Degrees Pharmaceuticals stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on XNAS exchange 60 Degrees Pharmaceuticals stocks are traded under the ticker SXTP.
Is 60 Degrees Pharmaceuticals stock price growing?▼
SXTP stock has fallen by -14.88% compared to the previous week, the month change is a -17.92% fall, over the last year 60 Degrees Pharmaceuticals has showed a -83.7% decrease.
What is 60 Degrees Pharmaceuticals market cap?▼
Today 60 Degrees Pharmaceuticals has the market capitalization of 3.23M
When is the next 60 Degrees Pharmaceuticals earnings date?▼
60 Degrees Pharmaceuticals is going to release the next earnings report on November 12, 2026.
What were 60 Degrees Pharmaceuticals earnings last quarter?▼
SXTP earnings for the last quarter are -0.9 USD per share, whereas the estimation was -0.74 USD resulting in a -22.45% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is 60 Degrees Pharmaceuticals revenue for the last year?▼
60 Degrees Pharmaceuticals revenue for the last year amounts to 1.41M USD.
What is 60 Degrees Pharmaceuticals net income for the last year?▼
SXTP net income for the last year is -7.37M USD.
How many employees does 60 Degrees Pharmaceuticals have?▼
As of September 07, 2026, the company has 3 employees.
In which sector is 60 Degrees Pharmaceuticals located?▼
60 Degrees Pharmaceuticals operates in the Health & Wellness sector.
When did 60 Degrees Pharmaceuticals complete a stock split?▼
The last stock split for 60 Degrees Pharmaceuticals was on January 20, 2026 with a ratio of 1:4.
Where is 60 Degrees Pharmaceuticals headquartered?▼
60 Degrees Pharmaceuticals is headquartered in WASHINGTON, United States.